The global market for GLP-1 drugs could reach $190 billion by 2035, more than double 2025 levels, according to an April report from Morgan Stanley Research
Genetic, environmental, and behavioral interactions have been linked to obesity
The full deal structure, the lead asset, and what it means for AstraZeneca's obesity pipeline is broken down on www.lifesciencedaily.news #AstraZeneca #Obesity #GLP1 #WeightManagement #Pharma #DrugDevelopment #Biopharma #LifeSciences #CSPC #ChinaPharma #Licensing To view or add a comment, sign in The obesity-diabetes drug market has emerged as one of the pharmaceutical industry's most lucrative and competitive segments, with leading companies generating tens of billions in annual revenue
Tart cherry juice contains this natural sleep aid that signals your body to wind down for a restful night's sleep
In treating your sore throat, we offer guidance on preventive measures to help avoid future issues
Dalhoff K, Ranek L, Mantoni M, Poulsen HE